Abstract |
Persistent immunity to hepatitis A and hepatitis B antibodies six years after vaccination of adolescents (aged 12-15 years) with a combined hepatitis A and B (HAB) vaccine following a 0, 6 month or a 0, 12 month schedule was assessed. Yearly (Year-2-6) serum samples were tested for anti-HAV and anti-HBs using EIA. Subjects with anti-HBs concentrations <10 mIU/mL (14/23) at Year-5 or Year-6, received an additional HBV vaccine dose approximately 12 months after Year-6. Blood samples were collected pre-booster and 1 month post-booster to assess booster response. 240 subjects were vaccinated in the study; at Year-6, data were available from 88 subjects. At that time 84.8% (39/46; 0, 6 month) and 92.9% (39/42; 0, 12 month) of subjects had anti-HBs concentrations > or = 10 mIU/mL. All but one of the 14 boosted subjects responded to the additional HBV vaccine dose with anti-HBs concentrations > or = 100 mIU/mL. All seroconverted subjects who returned at Year-6 were seropositive for anti-HAV. Simplification, reduced number of doses and similar long-term persistence of immunity make the 0, 6 month and 0, 12 month schedule preferable for immunization against HAV/HBV in this population.
|
Authors | Margaret A Burgess, Peter B McIntyre, Margaret Hellard, Tilman A Ruff, Inge Lefevre, Hans L Bock |
Journal | Vaccine
(Vaccine)
Vol. 28
Issue 10
Pg. 2222-2226
(Mar 02 2010)
ISSN: 1873-2518 [Electronic] Netherlands |
PMID | 20056187
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2010 Elsevier Ltd. All rights reserved. |
Chemical References |
- Hepatitis A Antibodies
- Hepatitis A Vaccines
- Hepatitis B Antibodies
- Hepatitis B Vaccines
- Vaccines, Combined
|
Topics |
- Adolescent
- Child
- Female
- Hepatitis A Antibodies
(blood)
- Hepatitis A Vaccines
(immunology)
- Hepatitis B Antibodies
(blood)
- Hepatitis B Vaccines
(immunology)
- Humans
- Immunization, Secondary
(methods)
- Male
- Time Factors
- Vaccination
(methods)
- Vaccines, Combined
(immunology)
- Young Adult
|